A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
Active, not recruiting · NCT05678010 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, metastatic neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-05-18 | NCT05678010 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Memorial Sloan Kettering Cancer Center | 753 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | United States | 92 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Commack | United States | 20 |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | United States | 86 |
| University of Washington (Data Collection AND Data Analysis) | Seattle | United States | 2 |